Top Healthcare Stocks In India by Market Capitalisation

Best healthcare stocks in India include Lupin Ltd with a 16.54% 1-year return, Torrent Pharmaceuticals Ltd at 13.75%, and Mankind Pharma Ltd at 9.29%, highlighting strong performers in the sector. Other notable stocks are Abbott India Ltd with 4.51% and Sun Pharmaceutical Industries Ltd with 4.09%, while major players like Dr. Reddy’s Laboratories Ltd, Zydus Lifesciences Ltd, and Alkem Laboratories Ltd saw negative returns over the past year. 

The table below shows the top healthcare stocks in India by market capitalisation and 1-year return.

Stock Name	Close Price ₹	Market Cap (In Cr)	1Y Return %
Sun Pharmaceutical Industries Ltd	1647.50	387156.69	4.09
Cipla Ltd	1441.15	118182.33	-3.11
Torrent Pharmaceuticals Ltd	2987.00	102584.51	13.75
Mankind Pharma Ltd	2294.20	96630.02	9.29
Dr Reddy’s Laboratories Ltd	1125.55	93990.82	-12.74
Zydus Lifesciences Ltd	886.45	88845.43	-5.98
Lupin Ltd	1891.05	86694.87	16.54
Abbott India Ltd	29963.75	64163.33	4.51
Aurobindo Pharma Ltd	1080.70	62787.56	3.36
Alkem Laboratories Ltd	4612.50	54565.88	-8.56

Introduction To Healthcare Stocks In India by Market Cap

Sun Pharmaceutical Industries Ltd

Sun Pharmaceutical Industries Limited, an Indian-based pharmaceutical company specializing in generic medications, is involved in the manufacturing, development, and marketing of a diverse range of branded and generic pharmaceutical formulations and active ingredients. 

The company offers a broad portfolio of generic and specialty medicines tailored for various chronic and acute medical conditions. With a vertically integrated network, Sun Pharma is capable of producing a wide array of pharmaceutical products, including oncology drugs, hormones, peptides, and steroidal medications. 

• Close Price ( ₹ ): 1647.50
• Market Cap ( Cr ): 387156.69
• 1Y Return %: 4.09
• 6M Return %: -7.93
• 1M Return %: -11.22
• 5Y CAGR %: 33.50
• % Away From 52W High: 18.99
• 5Y Avg Net Profit Margin %: 13.23 

Cipla Ltd

Cipla Limited, headquartered in India, is a pharmaceutical company primarily involved in the development, manufacturing, and distribution of generic and branded medications through its two operating segments: Pharmaceuticals and New ventures. 

The Pharmaceuticals segment focuses on producing and selling generic or branded generic drugs, as well as Active Pharmaceutical Ingredients (API). The New ventures segment encompasses consumer healthcare, Biosimilars, and specialty products. Cipla’s product portfolio includes a range of medications such as complex generics for respiratory, anti-retroviral, anti-infective, and central nervous system (CNS) conditions. 

• Close Price ( ₹ ): 1441.15
• Market Cap ( Cr ): 118182.33
• 1Y Return %: -3.11
• 6M Return %: -9.82
• 1M Return %: 3.81
• 5Y CAGR %: 27.89
• % Away From 52W High: 18.10
• 5Y Avg Net Profit Margin %: 12.05 

Torrent Pharmaceuticals Ltd

Torrent Pharmaceuticals Limited is an Indian pharmaceutical company that specializes in a range of therapeutic areas, including cardiovascular health, central nervous system disorders, gastrointestinal conditions, vitamins and minerals, diabetes management, pain relief, women’s health, and dermatology. 

The company is involved in all aspects of the pharmaceutical industry, from research and development to manufacturing, marketing, and distribution of both branded and generic medications in India and globally.

• Close Price ( ₹ ): 2987.00
• Market Cap ( Cr ): 102584.51
• 1Y Return %: 13.75
• 6M Return %: -11.15
• 1M Return %: -7.59
• 5Y CAGR %: 22.46
• % Away From 52W High: 20.21
• 5Y Avg Net Profit Margin %: 13.06 

Mankind Pharma Ltd

Mankind Pharma Limited is an Indian pharmaceutical company that is involved in the development, production, and promotion of a wide range of pharmaceutical products across various acute and chronic health conditions, as well as consumer healthcare items. 

The company offers a variety of formulations in therapeutic categories like anti-infectives, cardiovascular, gastrointestinal, vitamins/minerals/nutrients, respiratory, anti-diabetic, dermatology, gynecology, and pain relief, among others.

• Close Price ( ₹ ): 2294.20
• Market Cap ( Cr ): 96630.02
• 1Y Return %: 9.29
• 6M Return %: -5.48
• 1M Return %: -4.52 
• % Away From 52W High: 33.15
• 5Y Avg Net Profit Margin %: 17.47 

Dr Reddy’s Laboratories Ltd

Dr. Reddy’s Laboratories Limited is a pharmaceutical company headquartered in India with a global presence. The company provides a range of products and services, which include active pharmaceutical ingredients (APIs), generics, branded generics, biosimilars, and over-the-counter (OTC) medications. 

Its key focus areas in terms of therapeutic treatment include gastrointestinal, cardiovascular, diabetology, oncology, pain management, and dermatology. The company is divided into segments, namely Pharmaceutical Services and Active Ingredients, Global Generics, and Others. The Pharmaceutical Services and Active Ingredients segment primarily deals with the manufacturing and marketing of APIs and intermediates. 

• Close Price ( ₹ ): 1125.55
• Market Cap ( Cr ): 93990.82
• 1Y Return %: -12.74
• 6M Return %: -19.18
• 1M Return %: -7.86
• 5Y CAGR %: 12.91
• % Away From 52W High: 26.29
• 5Y Avg Net Profit Margin %: 13.57 

Zydus Lifesciences Ltd

Zydus Lifesciences Ltd is an Indian company that focuses on life sciences. The company is involved in various activities such as research, development, manufacturing, marketing, and selling of a range of products. 

This includes finished dosage human formulations like generics and specialty formulations, as well as biosimilars and vaccines, active pharmaceutical ingredients (APIs), animal healthcare products, and consumer wellness products. 

• Close Price ( ₹ ): 886.45
• Market Cap ( Cr ): 88845.43
• 1Y Return %: -5.98
• 6M Return %: -20.44
• 1M Return %: -7.06
• 5Y CAGR %: 27.66
• % Away From 52W High: 49.39
• 5Y Avg Net Profit Margin %: 15.80 

Lupin Ltd

Lupin Limited, an India-based pharmaceutical company, focuses on producing, developing, and marketing a wide range of branded and generic formulations, biotechnology products, and active pharmaceutical ingredients (APIs) on a global scale. 

The company operates in various therapeutic segments such as Cardiovascular, Diabetology, Asthma, Pediatrics, Central Nervous System, Gastro-Intestinal, Anti-Infectives, Nonsteroidal Anti Inflammatory Drug therapy, Anti-TB, and Cephalosporins. 

• Close Price ( ₹ ): 1891.05
• Market Cap ( Cr ): 86694.87
• 1Y Return %: 16.54
• 6M Return %: -12.92
• 1M Return %: -9.93
• 5Y CAGR %: 23.33
• % Away From 52W High: 27.07
• 5Y Avg Net Profit Margin %: 1.83 

Abbott India Ltd

Abbott India Limited is an Indian company operating in the pharmaceutical industry. The company offers a range of products in diagnostics, medical devices, nutrition, and generic medicines. 

Their product portfolio covers various therapeutic areas including women’s health, gastroenterology, central nervous system, metabolic disorders, and vaccines. Additionally, the company provides well-known brands like Similac, PediaSure, and Ensure in the market.

• Close Price ( ₹ ): 29963.75
• Market Cap ( Cr ): 64163.33
• 1Y Return %: 4.51
• 6M Return %: 0.76
• 1M Return %: 11.02
• 5Y CAGR %: 13.11
• % Away From 52W High: 2.35
• 5Y Avg Net Profit Margin %: 16.50 

Aurobindo Pharma Ltd

Aurobindo Pharma Limited is an Indian pharmaceutical company that specializes in manufacturing and marketing various pharmaceutical products and services. The company’s product range covers seven therapeutic areas including Central Nervous System, Antiretrovirals, Cardiovascular, Oral and Sterile products, Anti-infectives, Anti-diabetics, and Oral Cephalosporins. 

Aurobindo Pharma is also developing oncology and hormonal products, as well as topical and transdermal products in dermatology. They are working on three depot injections using advanced technology platforms. The company sells its products in around 150 countries globally and has subsidiaries such as APL Healthcare Limited, Auronext Pharma Private Limited, Auro Peptides Limited, and APL Pharma Thai Limited.

• Close Price ( ₹ ): 1080.70
• Market Cap ( Cr ): 62787.56
• 1Y Return %: 3.36
• 6M Return %: -30.37
• 1M Return %: -9.68
• 5Y CAGR %: 15.78
• % Away From 52W High: 47.31
• 5Y Avg Net Profit Margin %: 12.10 

Alkem Laboratories Ltd

Alkem Laboratories Limited is an Indian company that operates globally in the pharmaceutical industry. The company is involved in the research, production, and distribution of pharmaceutical and nutritional products across a range of therapeutic areas such as Anti Infective, Dermatology, Diabetology, Cardiology, and more. 

Alkem offers a variety of products including prescription medications, generic drugs, and over-the-counter products under brands like Clavam, Pan, and Taxim. The company has a presence in 40 countries and operates through its Pharmaceuticals segment with around 800 brands. 

• Close Price ( ₹ ): 4612.50
• Market Cap ( Cr ): 54565.88
• 1Y Return %: -8.56
• 6M Return %: -21.70
• 1M Return %: -9.04
• 5Y CAGR %: 11.79
• % Away From 52W High: 39.62
• 5Y Avg Net Profit Margin %: 13.63  

What Are Healthcare Stocks In India?

Healthcare stocks in India refer to shares of companies involved in pharmaceuticals, hospitals, diagnostics, biotechnology, and medical devices. Leading players like Sun Pharmaceutical, Cipla, and Dr. Reddy’s Laboratories dominate the sector, benefiting from rising healthcare demand, medical advancements, and government initiatives promoting affordable healthcare and innovation. 

Features Of Healthcare Stocks In India by Market Cap

The key features of healthcare stocks in India by market capitalization include strong demand, government support, and technological advancements. These companies benefit from rising healthcare needs, expanding medical infrastructure, and increasing investments in pharmaceuticals, diagnostics, and hospitals, driving long-term growth potential.

1. Market Leaders & Industry Share
Top healthcare companies like Sun Pharmaceutical, Cipla, and Dr. Reddy’s Laboratories dominate the sector. Their large market capitalization, global reach, and research-driven approach ensure stability, making them attractive for long-term investment and portfolio diversification.

2. Rising Demand for Healthcare Services
India’s growing population, increasing life expectancy, and rising prevalence of chronic diseases fuel demand for healthcare services. Pharmaceuticals, hospitals, and diagnostic chains benefit from this steady demand, ensuring consistent revenue growth and expansion opportunities.

3. Government Policies & Support
The healthcare sector receives significant government support through initiatives like Ayushman Bharat and PLI schemes. These policies promote domestic production, lower healthcare costs, and enhance accessibility, benefiting companies with strong market presence and regulatory compliance.

4. Technological Advancements & R&D Investment
Innovation in biotechnology, telemedicine, and AI-driven diagnostics is transforming the industry. Companies investing in research and development (R&D) gain a competitive advantage, ensuring sustained growth and strong stock performance over time.

5. Defensive Nature & Stability
Healthcare stocks are relatively less volatile compared to cyclical industries. Their defensive nature, driven by essential demand, makes them resilient during economic downturns, providing consistent returns to investors even in challenging market conditions.

Best Healthcare Stocks In India by Market Cap

The table below shows the best healthcare stocks in India by market cap and 6-month return.

Stock Name	Close Price ₹	Market Cap (In Cr)	6M Return %
Abbott India Ltd	29963.75	64163.33	0.76
Mankind Pharma Ltd	2294.20	96630.02	-5.48
Sun Pharmaceutical Industries Ltd	1647.50	387156.69	-7.93
Cipla Ltd	1441.15	118182.33	-9.82
Torrent Pharmaceuticals Ltd	2987.00	102584.51	-11.15
Lupin Ltd	1891.05	86694.87	-12.92
Dr Reddy’s Laboratories Ltd	1125.55	93990.82	-19.18
Zydus Lifesciences Ltd	886.45	88845.43	-20.44
Alkem Laboratories Ltd	4612.50	54565.88	-21.7
Aurobindo Pharma Ltd	1080.70	62787.56	-30.37

Top Healthcare Stocks by Market Cap

The table below shows the top healthcare stocks by market cap and 1-month return.

Stock Name	Close Price ₹	Market Cap (In Cr)	1M Return %
Abbott India Ltd	29963.75	64163.33	11.02
Cipla Ltd	1441.15	118182.33	3.81
Mankind Pharma Ltd	2294.20	96630.02	-4.52
Zydus Lifesciences Ltd	886.45	88845.43	-7.06
Torrent Pharmaceuticals Ltd	2987.00	102584.51	-7.59
Dr Reddy’s Laboratories Ltd	1125.55	93990.82	-7.86
Alkem Laboratories Ltd	4612.50	54565.88	-9.04
Aurobindo Pharma Ltd	1080.70	62787.56	-9.68
Lupin Ltd	1891.05	86694.87	-9.93
Sun Pharmaceutical Industries Ltd	1647.50	387156.69	-11.22

Healthcare Stocks In India by Market Cap

The table below shows the healthcare stocks in India by market cap and 5-year average net profit margin.

Stock Name	Close Price ₹	Market Cap (In Cr)	5Y Avg Net Profit Margin %
Mankind Pharma Ltd	2294.20	96630.02	17.47
Abbott India Ltd	29963.75	64163.33	16.5
Zydus Lifesciences Ltd	886.45	88845.43	15.8
Alkem Laboratories Ltd	4612.50	54565.88	13.63
Dr Reddy’s Laboratories Ltd	1125.55	93990.82	13.57
Sun Pharmaceutical Industries Ltd	1647.50	387156.69	13.23
Torrent Pharmaceuticals Ltd	2987.00	102584.51	13.06
Aurobindo Pharma Ltd	1080.70	62787.56	12.1
Cipla Ltd	1441.15	118182.33	12.05
Lupin Ltd	1891.05	86694.87	1.83

High Dividend Yield Healthcare Stocks In India by Market Cap

The table below shows the high dividend yield healthcare stocks in India by market cap.

Stock Name	Close Price ₹	Market Cap (In Cr)	Dividend Yield %
Abbott India Ltd	29963.75	64163.33	1.36
Torrent Pharmaceuticals Ltd	2987.00	102584.51	0.92
Cipla Ltd	1441.15	118182.33	0.89
Alkem Laboratories Ltd	4612.50	54565.88	0.88
Sun Pharmaceutical Industries Ltd	1647.50	387156.69	0.84
Dr Reddy’s Laboratories Ltd	1125.55	93990.82	0.71
Lupin Ltd	1891.05	86694.87	0.42
Aurobindo Pharma Ltd	1080.70	62787.56	0.42
Zydus Lifesciences Ltd	886.45	88845.43	0.34

Historical Performance Of Healthcare Stocks In India

The table below shows the historical performance of healthcare stocks in India and the 5-year CAGR.

Stock Name	Close Price ₹	Market Cap (In Cr)	5Y CAGR %
Sun Pharmaceutical Industries Ltd	1647.50	387156.69	33.5
Cipla Ltd	1441.15	118182.33	27.89
Zydus Lifesciences Ltd	886.45	88845.43	27.66
Lupin Ltd	1891.05	86694.87	23.33
Torrent Pharmaceuticals Ltd	2987.00	102584.51	22.46
Aurobindo Pharma Ltd	1080.70	62787.56	15.78
Abbott India Ltd	29963.75	64163.33	13.11
Dr Reddy’s Laboratories Ltd	1125.55	93990.82	12.91
Alkem Laboratories Ltd	4612.50	54565.88	11.79

Factors To Consider When Investing In Healthcare Stocks

The factors to consider when investing in healthcare stocks include evaluating financial strength, market position, regulatory environment, and research investments. Fundamental analysis helps investors assess a company’s growth potential, stability, and profitability in this essential and evolving sector.

1. Revenue Growth & Profitability
Investors should analyze consistent revenue growth, profit margins, and return on equity (ROE) to determine a company’s financial health. Strong sales in pharmaceuticals, hospitals, or diagnostics indicate stable demand and long-term investment potential.

2. Debt Levels & Financial Stability
Healthcare companies often require high capital for research, infrastructure, and expansion. Checking the debt-to-equity ratio and cash flow helps investors gauge whether a company can sustain operations and growth without excessive financial burden.

3. Research & Development (R&D) Investments
Companies with high R&D spending gain a competitive edge by developing new drugs, medical devices, or treatments. A strong pipeline of innovative products ensures future revenue growth and enhances stock valuation.

4. Regulatory Compliance & Government Policies
Healthcare companies must comply with FDA, DCGI, and global health regulations. Investors should assess how government policies, price controls, and changing regulations impact profitability and market access.

5. Market Share & Competitive Advantage
Industry leaders like Sun Pharma and Cipla benefit from strong branding, global reach, and exclusive product approvals. Analyzing a company’s patents, licensing agreements, and international presence helps investors choose fundamentally strong healthcare stocks.

How To Invest In Best Healthcare Stocks In India by Market Cap?

With Alice Blue, you can invest in the best healthcare stocks in India by market cap seamlessly and enjoy zero brokerage on equity delivery trades. Follow these simple steps to start investing:

• Open a Demat & Trading Account – Sign up on Alice Blue, complete KYC, and get your account activated.
• Add Funds – Deposit money into your trading account via UPI, Net Banking, or NEFT/RTGS.
• Search & Buy Stocks – Absolutely Free – Find your preferred stock, select Market Order (instant buy) or Limit Order (buy at your set price), and confirm the purchase. 

No brokerage fees on stock purchases!

• Track & Manage Investments – Monitor your portfolio, set price alerts, and stay updated with market insights.

Benefits Of Best Healthcare Stocks In India

The main advantages of investing in the best healthcare stocks in India include stable demand, growth potential, and government support. These stocks benefit from increasing healthcare needs, technological advancements, and global pharmaceutical exports, ensuring long-term profitability and resilience against economic fluctuations.

1. Strong Market Demand & Stability
Healthcare is an essential sector with a consistent demand for medicines, hospitals, and diagnostics. This ensures stability in stock performance, making healthcare stocks a defensive investment option even during economic downturns and market uncertainties.

2. Growth Driven by Aging Population & Lifestyle Diseases
India’s aging population and rising chronic diseases like diabetes and cardiovascular conditions fuel long-term demand for healthcare services. Companies focusing on pharmaceuticals, medical devices, and preventive healthcare stand to benefit from this growing healthcare need.

3. Government Support & Policy Initiatives
Initiatives like Ayushman Bharat, Production Linked Incentive (PLI) schemes, and drug price regulations support domestic healthcare companies. These policies enhance accessibility, promote local manufacturing, and improve profitability, benefiting leading healthcare stocks.

4. Innovation & Research-Driven Expansion
Top pharmaceutical companies invest in biotech, vaccines, and cutting-edge drug development. Firms with strong R&D pipelines have higher growth potential, expanding their market reach both domestically and internationally, leading to better stock performance.

5. Export Potential & Global Market Reach
Many Indian pharmaceutical companies have a significant presence in global markets, exporting medicines to the US, Europe, and emerging economies. Strong international demand ensures revenue diversification, reducing dependency on domestic market fluctuations and enhancing stock value.

Risks Of Investing In Healthcare Stocks In India

The main risk of investing in healthcare stocks in India comes from regulatory challenges, pricing pressures, and high research costs. Investors must carefully analyze financial stability, competitive positioning, and evolving market trends to mitigate potential risks and ensure long-term profitability.

1. Regulatory & Compliance Risks
Healthcare companies must adhere to strict government policies, FDA approvals, and drug pricing regulations. Any regulatory changes or non-compliance can result in heavy fines, product recalls, or delays in drug approvals, affecting stock performance.

2. Pricing Pressure & Profit Margins
Price controls on essential medicines and government policies like Drug Price Control Order (DPCO) can limit profitability. Companies with a heavy reliance on regulated drug pricing may struggle with shrinking margins and revenue growth.

3. High Research & Development (R&D) Costs
Pharmaceutical and biotech firms invest heavily in R&D for drug discovery and clinical trials. Unsuccessful research projects or delayed approvals can lead to massive losses, impacting stock valuation and long-term investor confidence.

4. Market Competition & Patent Expiry
The healthcare industry faces intense competition from domestic and global players. Patent expirations allow generic drug manufacturers to enter the market, reducing exclusivity and impacting sales of branded pharmaceutical products.

Who Should Invest In Healthcare Stocks In India?

Investors looking for long-term stability, defensive sector exposure, and growth potential should consider healthcare stocks in India. With rising healthcare demand, government support, and innovation in pharmaceuticals and diagnostics, these stocks suit those seeking consistent returns and industry diversification.

1. Long-Term Growth Investors
Healthcare stocks benefit from rising population, aging demographics, and increasing medical needs. Investors with a long-term perspective can capitalize on the sector’s consistent demand and innovation-driven expansion, ensuring steady returns over time.

2. Defensive & Low-Volatility Investors
Healthcare is a defensive sector, meaning it remains stable during economic downturns. Investors looking for low-volatility stocks with steady demand should consider leading pharmaceutical and hospital companies for portfolio stability.

3. Dividend & Passive Income Seekers
Established healthcare companies with strong cash flows and profitability often provide regular dividends. Investors seeking passive income can benefit from these stocks while also gaining exposure to the healthcare sector’s long-term growth.

4. Sector-Specific & Ethical Investors
Those interested in pharmaceuticals, biotechnology, diagnostics, or medical devices can focus on healthcare stocks. Ethical investors who support companies involved in life-saving drugs, medical research, and healthcare accessibility may find this sector appealing. 

FAQs – Best Healthcare Stocks In India by Market Cap

Disclaimer: The above article is written for educational purposes, and the companies’ data mentioned in the article may change with respect to time The securities quoted are exemplary and are not recommendatory.